e-learning
resources
Copenhagen 2005
Wednesday 21.09.2005
Management of tuberculosis pulmonary, extrapulmonary peculiarities
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Determination of drug susceptibility of
Mycobacterium tuberculosis
through mycolic acid analysis with HPLC technique - comparison to the conventional methods
R. Walkiewicz, H. Grubek-Jaworska, R. Chazan (Warsaw, Poland)
Source:
Annual Congress 2005 - Management of tuberculosis pulmonary, extrapulmonary peculiarities
Session:
Management of tuberculosis pulmonary, extrapulmonary peculiarities
Session type:
Oral Presentation
Number:
4538
Disease area:
Respiratory infections
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
R. Walkiewicz, H. Grubek-Jaworska, R. Chazan (Warsaw, Poland). Determination of drug susceptibility of
Mycobacterium tuberculosis
through mycolic acid analysis with HPLC technique - comparison to the conventional methods. Eur Respir J 2005; 26: Suppl. 49, 4538
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Expert interview: TB-Machine learning and artificial intelligence as allies in clinical decision
Late Breaking Abstract - Implications of treatable traits and treatment choices on exacerbation risk in moderate-severe asthma
Impact of Dexamethasone on pathogen profile of COVID-19 patients requiring intensive care: a multicentre retrospective study
Related content which might interest you:
Detection of isoniazid or rifampin resistant
Mycobacterium tuberculosis
in patients with cavity and previously treated for tuberculosis - usefulness of rapid drug susceptibility test with sputum samples by reverse hybridization assay
Source: Annual Congress 2005 - Resistant and multidrug resistant tuberculosis
Year: 2005
Comparison of
Mycobacterium tuberculosis
drug susceptibility tests by nucleic acid amplification and classic technique
Source: Eur Respir J 2001; 18: Suppl. 33, 315s
Year: 2001
In vitro
and
vivo
study of isoxyl, a mycolic acid inhibitor for intermittent chemotherapy of multi drug resistant (MDR) strains of
mycobacterium tuberculosis
(M.tb)
Source: Eur Respir J 2006; 28: Suppl. 50, 587s
Year: 2006
Comparative analysis of detection of Mycobacterium tuberculosis and rifampin resistance determination through microbiological and molecular genetics methods for pulmonary tuberculosis patients with presence or absence of sputum
Source: Annual Congress 2012 - Microbiological advances in the diagnosis of tuberculosis
Year: 2012
Evaluation of a molecular assay for detection of rifampin and isoniazid resistant
mycobacterium tuberculosis
in strains and clinical samples
Source: Annual Congress 2008 - Genetics, immunology and microbiology of tuberculosis
Year: 2008
Comparative analysis of M. tuberculosis drug susceptibility tests results in new multidrug-resistant tuberculosis cases and their confirmed contacts.
Source: Virtual Congress 2020 – Multidrug-resistant tuberculosis
Year: 2020
Application of the novel technique next gene sequencing for the determination of mycobacterium tuberculosis resistance in clinical samples
Source: Annual Congress 2013 –Tuberculosis diagnosis
Year: 2013
Rapid resistance detection of
Mycobacterium tuberculosis
to second-line drugs using the manual mycobacterium growth indicator tube (MGIT) system.
Source: Annual Congress 2008 - Epidemiology and clinical management of multidrug-resistant and extensively drug-resistant tuberculosis
Year: 2008
Microbiology of
Mycobacterium tuberculosis
and a new diagnostic test for TB
Source: Eur Respir Mon 2012; 58: 1-13
Year: 2012
Simultaneous detection of XDR genetic determinants and Mycobacterium tuberculosis genotyping by TB-TEST.
Source: International Congress 2017 – MDRTB: detection and management
Year: 2017
Method of treatment of destructive tuberculosis of single lung with extensively drug resistant mycobacteria tuberculosis
Source: Annual Congress 2011 - Extrapulmonary tuberculosis and surgical interventions
Year: 2011
Detection of fluoroquinolones resistance mutations in
mycobacterium tuberculosis
by hydrolysis probes and RFLP
Source: Annual Congress 2013 –Diagnostic features of tuberculosis II
Year: 2013
In vitro
and
in vivo
activity of thiourea (ISO), a mycolic acid inhibitor, against multi drug resistant (MDR) strains of
Mycobacterium tuberculosis
(
M. tb
)
Source: Eur Respir J 2005; 26: Suppl. 49, 700s
Year: 2005
Comparison of two commercial interferon-γ assays for diagnosing Mycobacterium tuberculosis infection
Source: Eur Respir J 2006; 28: 24-30
Year: 2006
Systematic evaluation of clarithromycin (CLA) resistance associated mutations in Mycobacterium abscessus complex based on whole-genome sequencing analysis and drug susceptibility testing.
Source: Virtual Congress 2020 – Translational science in respiratory infections
Year: 2020
Application of the method of biological microchips for control drug-resistant mycobacterium tuberculosis
Source: Annual Congress 2009 - Treatment of tuberculosis at times of emerging drug resistance
Year: 2009
Mycobacterium tuberculosis resistance
Source: Eur Respir J 2002; 20: Suppl. 38, 360s
Year: 2002
The WHO strategy for TB control and elimination
Source: Eur Respir Mon 2012; 58: 242-253
Year: 2012
The compare of the TB-Biochip oligonucleotide microarray system and bacteriological method for detection of rifampin and isoniazid resistance in mycobacterium tuberculosis
Source: Annual Congress 2008 - The challenge of multidrug-resistant tuberculosis
Year: 2008
Colorimetric assays for rapid drug susceptibility testing of
Mycobacterium tuberculosis
Source: Eur Respir J 2003; 22: Suppl. 45, 167s
Year: 2003
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept